Abbvie Inc [NYSE: ABBV] stock went on a downward path that fall over -2.40% on Friday, amounting to a one-week price decrease of less than -1.61%.
Over the last 12 months, ABBV stock rose by 2.59%. The one-year Abbvie Inc stock forecast points to a potential downside of -3487507.96. The average equity rating for ABBV stock is currently 1.87, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $322.03 billion, with 1.77 billion shares outstanding and 1.76 billion shares in the current float. Compared to the average trading volume of 7.43M shares, ABBV stock reached a trading volume of 29259309 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Abbvie Inc [ABBV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABBV shares is $213.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 1.87. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Abbvie Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 14, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on April 22, 2025, representing the official price target for Abbvie Inc stock. Previously, the target price had yet another raise to $191, while BofA Securities analysts kept a Neutral rating on ABBV stock.
The Price to Book ratio for the last quarter was 226.77, with the Price to Cash per share for the same quarter was set at 2.93. Price to Free Cash Flow for ABBV in the course of the last twelve months was 20.93 with Quick ratio for the last quarter at 0.64.
ABBV Stock Performance Analysis:
Abbvie Inc [ABBV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.61. With this latest performance, ABBV shares dropped by -0.43% in over the last four-week period, additionally plugging by 2.20% over the last 6 months – not to mention a rise of 2.59% in the past year of trading.
Insight into Abbvie Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Abbvie Inc [ABBV] shares currently have an operating margin of 30.74% and a Gross Margin at 70.80%. Abbvie Inc’s Net Margin is presently recorded at 7.24%.
Return on Equity for this stock inclined to 2.92%, with Return on Assets sitting at 2.92%.
ABBV Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABBV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Abbvie Inc go to 15.22%.
Abbvie Inc [ABBV] Institutonal Ownership Details
There are presently around $74.45%, or 74.53% of ABBV stock, in the hands of institutional investors. The top three institutional holders of ABBV stocks are: VANGUARD GROUP INC with ownership of 170.66 million shares, which is approximately 9.6472%. BLACKROCK INC., holding 136.43 million shares of the stock with an approximate value of $$23.4 billion in ABBV stocks shares; and BLACKROCK INC., currently with $$13.34 billion in ABBV stock with ownership which is approximately 4.398%.
